Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy (Adv. Sci. 16/2022)

Localized Scleroderma Therapy Human‐induced pluripotent stem cell (hiPSC)‐derived epithelial and mesenchymal (EM) organoids can be used to investigate the therapeutic potential for the recovery of localized scleroderma (LoS) associated phenotypes and skin‐associated functions. In article number 2106...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jie, Li, Wei, Cao, Ruiyuan, Gao, Dunqin, Zhang, Qiyu, Li, Xiao, Li, Biyou, Lv, Luye, Li, Mansheng, Jiang, Junyi, Wang, Yujie, Li, Jun, Wu, Zhihong, Zhu, Yunping, Zhong, Wu, Zhang, Shuyang, Leng, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Inside Back Cover
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165512/
http://dx.doi.org/10.1002/advs.202270104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165512/
http://dx.doi.org/10.1002/advs.202270104

Ejemplares similares